Markets - Seastock

Markets

While our current focus is on the production of Asparagopsis based methane reducing feed supplements for ruminant livestock, SeaStock is actively engaged in identifying additional adjacent markets for other seaweed-based compounds which are currently the focus of new and ongoing research worldwide.

SeaStock’s patent pending dual extraction method to release the natural compounds in Asparagopsis can also be applied to other seaweed and algae species.

Natural Bromoform (CHBr3)

Australia’s Asparagopsis forecast demand is estimated to be 75,000mt (wet weight) annually by 2030 to offset methane generated by ruminant livestock. Additionally there is a global opportunity to produce and export Asparagopsis based feed supplements and products to major ruminant livestock producing countries.

Food and Beverage

The demand for seaweed products in the food industry is increasing globally due to its proficiency in adding nutritional value to food products. Examples of algae based food products include as supplements to a range of meat products, fish, fish products and oils, cereal based products such as pasta, flour and break and fermented products including cheese, cream and yoghurt.

Cosmetics and personal care

Algal compounds can be used in a variety of cosmetic and personal care products with the market set to benefit from the continued focus on naturally derived, sustainable products.

Pharmaceuticals

High grade seaweed compounds have been proven for therapeutic use as an antioxidant, tumour suppressant, anti-inflammatory, anti-allergy, bacteria reduction and antiviral capacity among other identified uses. Compounds derived from seaweed and algae are currently in use across the pharmaceutical industry to treat a range of conditions including gall stones, stomach ailments, eczema, cancer, renal disorders, scabies, psoriasis, asthma, arteriosclerosis, heart disease, lung diseases and ulcers.